Dixon Technologies up 5% as Vivo JV approval nears

Stock jumps as clearance chatter returns

Dixon Technologies shares rose as reports suggested the government may clear the long-pending joint venture (JV) between Dixon and Chinese smartphone maker Vivo within the month. The stock hit an intraday high of Rs 12,859 per share on the NSE, a gain of 5%. The move extended a run of gains over the last four trading sessions, reflecting renewed investor focus on the company’s potential scale-up in mobile manufacturing.

The excitement has been driven by multiple reports indicating that an inter-ministerial process has moved forward. While there is no official government confirmation yet, the market reaction shows that the Vivo JV is being treated as a near-term catalyst for Dixon. Broker commentary has also kept attention on the stock, with some firms arguing the approval could meaningfully change revenue and earnings estimates over time.

What triggered the move in Dixon Technologies shares

The immediate trigger was reporting that an inter-ministerial panel has given in-principle approval to the deal. A source cited by PTI said the proposal will be cleared by the Ministry of Electronics and Information Technology (MeitY) after due process. Separately, NDTV Profit reported that an inter-ministerial committee gave a nod after a meeting held on a Saturday, adding to confidence that the file is progressing.

On Tuesday, Dixon Technologies also surged up to 3% in trade on similar newsflow about the government “closing in” on approval. By Wednesday, the stock extended gains, reflecting a market that has been positioning for a possible decision. The stock was also reported trading around Rs 12,248 in one session, up about 2.5%, showing how the price has reacted sharply to each incremental update.

The JV structure: 51% with Dixon, agreement signed in Dec 2024

Dixon Technologies and Vivo signed an agreement in December 2024 to set up a joint venture in which Dixon will hold a 51% stake. The structure is a key point because it aligns with the broader policy preference for Indian control in sensitive manufacturing partnerships.

The JV has been under review for months, and the current reports suggest it may be nearing the final stage of approvals. The government is yet to formally confirm the Vivo JV, but the repeated references to in-principle approval indicate that key stakeholders may have already weighed in.

Regulatory path: in-principle nod, MeitY process awaited

According to the PTI-cited source, an inter-ministerial panel has provided in-principle approval, with MeitY expected to clear the proposal after due process. NDTV Profit also indicated that an inter-ministerial committee backed the proposal after a meeting and that final approval would come after regulatory processes are completed.

This sequencing matters for investors because the market has been reacting not just to the eventual decision, but to evidence that the application has moved from deliberation to processing. Dixon’s management has also indicated in an earnings call that it is “deeply engaged with the government” and “very, very close” to securing approvals.

Vivo’s Noida manufacturing unit and the risk-reduction angle

Reports said Vivo’s manufacturing unit in Noida is likely to become part of the proposed venture. The rationale mentioned is that the arrangement could reduce Vivo’s risk exposure in India. For Dixon, integrating an existing facility into the JV could shorten the time needed to expand output, depending on the final structure and regulatory terms.

At the same time, the approval process has been complicated by references to an ongoing Enforcement Directorate (ED) probe into Vivo for alleged financial irregularities. That backdrop has been part of why investors and brokerages are watching timelines closely.

Scale potential: 20 to 22 million units and Rs 30,000 crore opportunity

The Vivo partnership has been positioned as a material scale driver for Dixon’s mobile manufacturing business. Management commentary referenced in the reports indicates the partnership could add 20 to 22 million smartphone units annually over time. Another report stated that operations are expected to start in Q3 FY27 and could contribute up to 22 million mobile volumes.

NDTV Profit also reported that Dixon is inching closer to a Rs 30,000 crore revenue opportunity if the JV is approved. The same reporting said the JV is expected to make almost 67% of Vivo’s total production, underlining the size of the proposed manufacturing footprint.

Key facts and figures at a glance

Broker views: JPMorgan bullish, others cautious

JPMorgan retained its ‘overweight’ rating on Dixon Technologies and maintained a target price of Rs 12,700 per share. The brokerage has described Dixon as its top pick in the EMS sector and argued that approval of the Vivo JV could still drive upside, countering the idea that it is already fully priced in. JPMorgan’s note also referenced potential upgrades to revenue estimates of 24% to 39% over a period, and an EPS upgrade of 13% to 18%, with a fair value estimate mentioned at Rs 15,100 and an upside of 23%.

Other brokerages have been more cautious. Motilal Oswal Financial Services downgraded the stock to ‘Reduce’ with a target price of Rs 10,560, citing near-term challenges such as mobile handset industry slowdown, rising memory prices, PLI incentive expiry, potential JV delays, and slower backward integration. Goldman Sachs maintained a ‘Sell’ rating and revised target price of Rs 9,790, pointing to elevated DRAM prices weighing on volumes and a subdued FY27 outlook for the mobile business.

JM Financial maintained an ‘Add’ rating but cut its 12-month target price to Rs 11,000 from Rs 13,800. It flagged global memory shortage concerns and said FY26E guidance could be cut from around 40 million smartphones to around 34 million, also noting uncertainty around FY27E volumes and delays in regulatory approvals for the Vivo JV.

Earnings context: profits fell in Q4 FY26

The JV narrative has been playing out against a mixed earnings backdrop. Dixon Technologies reported a 36.03% year-on-year decline in consolidated net profit for Q4 FY26 to Rs 256.41 crore, compared with Rs 400.82 crore a year earlier. Some reports noted that the stock’s rise appeared driven more by anticipation around the Vivo deal than by immediate quarterly performance.

This combination of near-term operational pressures and a potentially large medium-term catalyst is why sentiment remains divided. The stock has also been described as having seen a major drawdown over the past 12 months, and it traded near its reported 52-week low of Rs 9,600 in mid-May 2026.

What investors will track next: approvals, PLI 2.0, and ramp-up

In the short term, the market will watch for an official update on government approval and any details around conditions attached to the JV. JPMorgan has also highlighted a second catalyst: the announcement of a PLI 2.0 scheme. Separately, the execution path will matter, including how quickly the JV can commence operations in Q3 FY27 and whether volumes can ramp in FY27.

Investors will also track industry variables flagged by brokerages, including DRAM and memory availability, smartphone demand trends, and margin implications as PLI benefits change. These factors have been repeatedly cited as constraints on near-term handset volumes and profitability.

Conclusion

Dixon Technologies’ recent share price rise reflects renewed attention on the expected government decision on its Vivo joint venture, a deal signed in December 2024 with Dixon holding 51%. Reports point to in-principle backing by an inter-ministerial process and a MeitY clearance pending due process. The next clear trigger is formal approval and any timeline clarity on operations starting in Q3 FY27, alongside updates on PLI 2.0 and the pace of volume ramp-up.